Strategic Approaches in the Management of Tympanic Paragangliomas: A Single-Institutional Experience
摘要
Tympanic paragangliomas (glomus tympanicum tumors) are rare benign vascular neoplasms of middle ear paraganglionic tissue. This ambispective single-institutional study evaluates the strategic approaches adopted in the management of tympanic paragangliomas, analyzing the effectiveness of a newly implemented treatment algorithm with respect to surgical outcomes and recurrence rates. This study analyzed 28 patients with tympanic paragangliomas managed by a proposed algorithm between 2020 and 2024. Surgical approaches varied by tumor stage, from transcanal and endaural to mastoidectomy and infratemporal techniques. Key outcomes assessed included hearing preservation, recurrence, intraoperative complications, and long-term functional results. Of the 28 patients, 57.1% were female, and the median tumor size was 2.0 cm. The most common presenting symptoms were hearing loss (89.2%) and pulsatile tinnitus (85.7%). Surgical approaches varied based on tumor stage, with a majority undergoing either endaural or mastoidectomy procedures. Ossicular chain erosion was observed in 70.83% of cases. Postoperatively, hearing outcomes showed significant improvement or stabilization, with air-bone gap closure from 13.5 dB to 7.6 dB. Recurrence was observed in only one patient during the 18-month follow-up. No permanent facial nerve palsy occurred. The strategic management of glomus tympanicum tumors using a tailored approach based on tumor staging yields favourable long-term outcomes. Hearing preservation and low recurrence rates underscore the effectiveness of the newly implemented surgical algorithm, offering a refined approach to managing these complex middle ear tumors.